Contents

Brain Injury and Brain Death
Guidelines
Jul 2006 Prediction of Outcome in Comatose Survivors after Cardiopulmonary Resuscitation
Note: Current guideline. Clinician summary and patient summary available.
Jan 2003 Antiepileptic Drug Prophylaxis in Severe Traumatic Brain Injury
Note: Current guideline-reaffirmed 07/28/2006.
Mar 1997 The Management of Concussion in Sports
Note: Update in progress.
May 1995 Determining Brain Death in Adults
Note: Current guideline-reaffirmed on 01/13/2007 and 10/18/2003. Background paper and PDA version of guideline available.
May 1995 Assessment and Management of Patients in the Persistent Vegetative State
Note: Current guideline-reaffirmed 07/28/2006.
Tools
Clinician Summary Prediction of Outcome in Comatose Survivors after Cardiopulmonary Resuscitation
Patient Summary Prediction of Outcome in Comatose Survivors after Cardiopulmonary Resuscitation
PDA Version The Management of Concussion in Sports
PDA Version Determining Brain Death in Adults
Background/Data Determining Brain Death in Adults
back to top

Child Neurology
Guidelines
Nov 2006 Diagnostic Assessment of the Child with Status Epilepticus
Note:Current guideline. Clinician summary and patient and caregiver summary available.
Jul 2006 Prediction of Outcome in Comatose Survivors after Cardiopulmonary Resuscitation
Note: Current guideline. Clinician summary and patient summary available.
Sep 2005 Use of Serum Prolactin in Diagnosing Epileptic Seizures
Note: Current guideline. PowerPoint educational tool and PDA version available.
Jan 2005 Corticosteroid Treatment of Duchenne Dystrophy
Note: Reaffirmed on 02/08/2008. Current guideline. Clinician summary, patient and caregiver summary of guideline, and PowerPoint educational tool are available.
Dec 2004 Pharmacological Treatment of Migraine Headache in Children and Adolescents
Note: Current guideline. Clinician summary, patient and caregiver summary of guideline, and PowerPoint educational tool are available.
May 2004 Medical Treatment of Infantile Spasms
Note: Current guideline. Clinician summary, patient and caregiver summary, and PowerPoint educational tool are available.
Apr 2004 Efficacy and Tolerability of the New Antiepileptic Drugs, II: Treatment of Refractory Epilepsy
Note: Update in Progress. PowerPoint educational tool, clinician summary, and patient and caregiver summary available.
Apr 2004 Efficacy and Tolerability of the New Antiepileptic Drugs, I: Treatment of New Onset Epilepsy
Note: Update in progress. PowerPoint educational tool, clinician summary, and patient and caregiver summary available.
Mar 2004 Diagnostic Assessment of the Child with Cerebral Palsy
Note: Current guideline. Reaffirmed on 07/21/2007. Clinician summary, patient and caregiver summary, and PowerPoint educational tool are available.
Sep 2003 Immunotherapy for Guillain-Barré Syndrome
Note: Current guideline-reaffirmed 10/15/2005. Supplemental data, slide presentation, clinician summary, and patient and caregiver summary available.
Mar 2003 Temporal Lobe and Localized Neocortical Resections for Epilepsy
Note: Current guideline-reaffirmed 10/15/2005. Patient and caregiver version and supplemental data available.
Feb 2003 Evaluation of the Child with Global Developmental Delay
Note: Current guideline-reaffirmed 10/15/2005. Additional information on recommended tests provided. Clinician summary, patient and caregiver summary, and PowerPoint educational tool available.
Jan 2003 Treatment of the Child with a First Unprovoked Seizure
Note: Current guideline-reaffirmed 07/28/2006.
Aug 2002 Evaluation of Children and Adolescents with Recurrent Headache
Note: Current guideline-reaffirmed 10/15/2005 and 10/18/2003.
Jun 2002 Neuroimaging of the Neonate
Note: Current guideline-reaffirmed 10/15/2005. Supplemental data available.
Sep 2000 Evaluating the First Nonfebrile Seizure in Children
Note: Current guideline-reaffirmed 07/28/2006 and 10/18/2003.
Aug 2000 Screening and Diagnosis of Autism
Note: Current guideline-reaffirmed 07/28/2006 and 10/18/2003. Early identification and intervention can improve outcomes for toddlers and preschoolers with autism. Clinician summary, patient and caregiver summary, and PowerPoint educational tool are available.
Mar 1997 The Management of Concussion in Sports
Note: Update in progress.
May 1995 Assessment and Management of Patients in the Persistent Vegetative State
Note: Current guideline-reaffirmed 07/28/2006.
Tools
Patient Summary Diagnostic Assessment of the Child with Status Epilepticus
Clinician Summary Diagnostic Assessment of the Child with Status Epilepticus
PDA Version Corticosteroid Treatment of Duchenne Dystrophy
PDA Version Pharmacological Treatment of Migraine Headache in Children and Adolescents
Slide Presentation Corticosteroid Treatment of Duchenne Dystrophy
Note: PowerPoint presentation based on the corticosteroid treatment of DD guideline. Download slide presentation and use in grand rounds, lectures, or education settings.
Clinician Summary Corticosteroid Treatment of Duchenne Dystrophy
Patient Summary Corticosteroid Treatment of Duchenne Dystrophy
Clinician Summary Pharmacological Treatment of Migraine Headache in Children and Adolescents
Patient Summary Pharmacological Treatment of Migraine Headache in Children and Adolescents
Slide Presentation Pharmacological Treatment of Migraine Headache in Children and Adolescents
Note: PowerPoint presentation based on the pharmacological treatment of migraine headache in children and adolescents guideline. Download slide presentation and use in grand rounds, lectures, or education settings.
Slide Presentation Medical Treatment of Infantile Spasms
Note: PowerPoint presentation based on the Medical Treatment of Infantile Spasms guideline. Download slide presentation and use in grand rounds, lectures, or education settings.
Clinician Summary Medical Treatment of Infantile Spasms
Patient Summary Medical Treatment of Infantile Spasms
Slide Presentation Diagnostic Assessment of the Child with Cerebral Palsy
Note: PowerPoint presentation based on the Diagnostic assessment of the child with cerebral palsy guideline. Download slide presentation and use in grand rounds, lectures, or education settings.
Patient Summary Diagnostic Assessment of the Child with Cerebral Palsy
Clinician Summary Diagnostic Assessment of the Child with Cerebral Palsy
Slide Presentation Evaluation of the Child with Global Developmental Delay
Note: PowerPoint presentation based on the Evaluation of the child with global developmental delay guideline. Download slide presentation and use in grand rounds, lectures, or education settings.
Clinician Summary Evaluation of the Child with Global Developmental Delay
Patient Summary Evaluation of the Child with Global Developmental Delay
Background/Data Global Developmental Delay Appendix
Note: Information regarding selected tests.
Background/Data Neuroimaging of the Neonate Background Data
Note: Supplemental data.
Patient Summary Screening and Diagnosis of Autism
Slide Presentation Screening and Diagnosis of Autism
Note: PowerPoint presentation based on the Screening and diagnosis of autism guideline. Download slide presentation and use in grand rounds, lectures, or education settings.
Clinician Summary Screening and Diagnosis of Autism
back to top

Dementia
Alzheimer's disease can be reliably diagnosed; early diagnosis is possible and important. While Alzheimer's disease is not curable, there are treatment and care options available today.
Guidelines
May 2001 Diagnosis of Dementia
Note: Current guideline-reaffirmed 02/13/2004. Replaces Practice parameter for diagnosis and evaluation of dementia (Summary statement) 11/1994. Patient and caregiver summary and clinician summary available.
May 2001 Detection of Dementia and Mild Cognitive Impairment
Note: Current guideline-reaffirmed 10/18/2003. Patient and caregiver summary and clinician summary available under Diagnosis of Dementia.
May 2001 Management of Dementia
Note: Under revision 10/15/2005. Reaffirmed 10/18/2003. Patient and caregiver summary and clinician summary available under Diagnosis of Dementia.
Jan 2000 Risk of Driving and Alzheimer's Disease
Note: Update in progress.
Aug 1996 Neuropsychological Testing of Adults
Note: Retired 07/28/2006. Not available to download.
Tools
PDA Version Diagnosis of Dementia
PDA Version Management of Dementia
Background/Data AAN Encounter Kit for Dementia
Patient Summary Alzheimer's Disease Guidelines Summary for Patients, Families, and Friends
Clinician Summary Dementia Guidelines
back to top

Epilepsy
Guidelines
Nov 2007 Practice Parameter: Evaluating an apparent unprovoked first seizure in adults (an evidence-based review)
Note:Current guideline. Clinician summary and Patient and Caregiver summary available.
Oct 2007 Reassessment: Neuroimaging in the Emergency Patient Presenting with Seizure
Note:Current guideline. Clinician Summary and Case Study available.
Sep 2005 Use of Serum Prolactin in Diagnosing Epileptic Seizures
Note: Current guideline. PowerPoint educational tool and PDA version available.
Apr 2004 Efficacy and Tolerability of the New Antiepileptic Drugs, II: Treatment of Refractory Epilepsy
Note: Update in Progress. PowerPoint educational tool, clinician summary, and patient and caregiver summary available.
Apr 2004 Efficacy and Tolerability of the New Antiepileptic Drugs, I: Treatment of New Onset Epilepsy
Note: Update in progress. PowerPoint educational tool, clinician summary, and patient and caregiver summary available.
Mar 2003 Temporal Lobe and Localized Neocortical Resections for Epilepsy
Note: Current guideline-reaffirmed 10/15/2005. Patient and caregiver version and supplemental data available.
Jan 2003 Treatment of the Child with a First Unprovoked Seizure
Note: Current guideline-reaffirmed 07/28/2006.
Sep 2000 Evaluating the First Nonfebrile Seizure in Children
Note: Current guideline-reaffirmed 07/28/2006 and 10/18/2003.
Sep 1999 Reassessment: Vagus Nerve Stimulation for Epilepsy (UPDATED)
Note: Guideline under update. Guideline was reaffirmed on 10/17/2003. Supplement to Assessment of vagus nerve stimulation for epilepsy (07/1997).
May 1999 The Use of Felbamate in the Treatment of Patients with Intractable Epilepsy
Note:Current guideline. Reaffirmed 10/28/2006 and 10/18/2003.
Oct 1998 Management Issues for Women with Epilepsy
Note: Update in progress. Clinician summary available.
Jul 1997 Digital EEG, Quantitative EEG, and EEG Brain Mapping
Note: Current guideline-reaffirmed on 12/09/2006 and 10/17/2003. Replaces Assessment of digital EEG, quantitative EEG, and EEG brain mapping (08/1989).
Jul 1997 Assessment of Vagus Nerve Stimulation for Epilepsy
Note: Supplemented by Reassessment: Vagus nerve stimulation for epilepsy (1999)
Tools
Case Study Case Study: Evaluating an Apparent Unprovoked First Seizure in Adults and Coding
Patient Summary Practice Parameter: Evaluating an apparent unprovoked first seizure in adults (an evidence-based review)
Clinician Summary Practice Parameter: Evaluating an apparent unprovoked first seizure in adults (an evidence-based review)
Background/Data Case Study - Reassessment: Neuroimaging in the Emergency Patient Presenting with Seizure
Clinician Summary Reassessment: Neuroimaging in the Emergency Patient Presenting with Seizure
PDA Version Efficacy and Tolerability of the New Antiepileptic Drugs II: Treatment of Refractory Epilepsy
PDA Version Efficacy and Tolerability of the New Antiepileptic Drugs I: Treatment of New Onset Epilepsy
PDA Version Use of Serum Prolactin in Diagnosing Epileptic Seizures
Slide Presentation Use of Serum Prolactin in Diagnosing Epileptic Seizures
Slide Presentation Efficacy and Tolerability of the New Antiepileptic Drugs, I: Treatment of New Onset Epilepsy
Note: PowerPoint presentation based on the AED for treatment of new onset epilepsy guideline. Download slide presentation and use in grand rounds, lectures, or education settings.
Slide Presentation Efficacy and Tolerability of the New Antiepileptic Drugs, II: Treatment of Refractory Epilepsy
Note: PowerPoint presentation based on the AED for treatment of refractory epilepsy guideline. Download slide presentation and use in grand rounds, lectures, or education settings.
Patient Summary Efficacy and Tolerability of the New Antiepileptic Drugs, I: Treatment of New Onset Epilepsy
Clinician Summary Efficacy and Tolerability of the New Antiepileptic Drugs, II: Treatment of Refractory Epilepsy
Patient Summary Efficacy and Tolerability of the New Antiepileptic Drugs, II: Treatment of Refractory Epilepsy
Patient Summary Treatments for Refractory Epilepsy: Anti-Epileptic Drugs; Temporal Lobe Localized Neocortical Resections; Vagus Nerve Stimulation
Clinician Summary Efficacy and Tolerability of the New Antiepileptic Drugs, I: Treatment of New Onset Epilepsy
Clinician Summary Treatments for Refractory Epilepsy: Anti-Epileptic Drugs; Temporal Lobe Localized Neocortical Resections
Background/Data Temporal Lobe and Localized Neocortical Resections for Epilepsy
Note: Supplemental data.
Clinician Summary Management Issues for Women with Epilepsy
back to top

Headache
Guidelines
Aug 2005 Addendum to Assessment: Prevention of post-lumbar puncture headaches
Note: Current guideline. Reaffirmed on 02/09/2008. See Addendum to Prevention of Post-lumbar Puncture Headache (10/2000). PDA version available.
Dec 2004 Pharmacological Treatment of Migraine Headache in Children and Adolescents
Note: Current guideline. Clinician summary, patient and caregiver summary of guideline, and PowerPoint educational tool are available.
Aug 2002 Evaluation of Children and Adolescents with Recurrent Headache
Note: Current guideline-reaffirmed 10/15/2005 and 10/18/2003.
Oct 2000 Prevention of Post-Lumbar Puncture Headache
Note: See Addendum: Prevention of post-lumbar puncture headaches 08/2005.
Sep 2000 Evidence-based Guidelines for Migraine Headache
Note: Update in Progress. Migraine is a neurobiological disorder that occurs in 18 percent of women and six percent of men, but may be under-diagnosed or under-treated; preventive therapies are available. Background reports, patient and caregiver summary and clinician summary available.
Jul 1995 Electroencephalogram in the Evaluation of Headache
Note: Current guideline. Reaffirmed on 10/28/2006.
Tools
PDA Version Pharmacological Treatment of Migraine Headache in Children and Adolescents
PDA Version Addendum to Assessment: Prevention of Post–Lumbar Puncture Headaches
Patient Summary Pharmacological Treatment of Migraine Headache in Children and Adolescents
Clinician Summary Pharmacological Treatment of Migraine Headache in Children and Adolescents
Slide Presentation Pharmacological Treatment of Migraine Headache in Children and Adolescents
Note: PowerPoint presentation based on the pharmacological treatment of migraine headache in children and adolescents guideline. Download slide presentation and use in grand rounds, lectures, or education settings.
Patient Summary Evidence-based Guidelines for Migraine Headache
Clinician Summary Evidence-based Guidelines for Migraine Headache
Background/Data AAN Encounter Kit for Headache
Note: The AAN Encounter Kit for Headache includes: Physician Decision Support tools; Patient Education tools; Patient Assessment tools; and Business and Office Support tools.
Background/Data Evidence-based Guidelines for Migraine Headache: Behavioral and Physical Treatments
Note: Current background.
Background/Data Evidence-based Guidelines for Migraine Headache: Neuroimaging in Patients with Nonacute Headache
Note: Current background. Replaces Practice Parameter: the utility of neroimaging in the evaluation of headache in patients with normal neurologic examinations.
Background/Data Evidence-based Guidelines for Migraine Headache: Overview of Program Description and Methodology
Note: Current background.
Background/Data Evidence-based Guidelines for Migraine Headache: Pharmacological Management for Prevention of Migraine
Note: Current background.
Background/Data Evidence-based Guidelines for Migraine Headache: Pharmacological Management of Acute Attacks
Note: Current background.
back to top

Movement Disorders
Guidelines
Apr 2006 Neuroprotective strategies and alternative therapies for Parkinson disease
Note:Current guideline. Slide presentation and PDA version of guideline available.
Apr 2006 Treatment of Parkinson disease with motor fluctuations and dyskinesias
Note:Current guideline. Slide presentation, patient and caregiver summary, clinician summary and PDA version of guideline available.
Apr 2006 Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease
Note:Current guideline. Slide presentation, patient and caregiver summary, clinician summary and PDA version of guideline available.
Apr 2006 Diagnosis and prognosis of new onset Parkinson disease
Note:Current guideline. Slide presentation, patient and caregiver summary, clinician summary and PDA version of guideline available.
Jun 2005 Therapies for Essential Tremor
Note: Current guideline. Clinician summary, patient and caregiver summary, slide presentation and PDA version of guideline available.
Jan 2002 Initiation of Treatment for Parkinson's Disease (UPDATED)
Note: Current guideline-reaffirmed 10/15/2005 and 10/18/2003. Replaces Practice Parameters: Initial therapy of Parkinson's disease (Summary Statement) 7/1993. PDA version of guideline available.
Tools
Slide Presentation Treatment of Parkinson Disease with Motor Fluctuations and Dyskinesia with Audio
Slide Presentation Treatment of Parkinson Disease with Motor Fluctuations and Dyskinesia without Audio
Clinician Summary Diagnosis, Prognosis, Neuroprotection, Initiation of Treatment, and Alternative Therapies for Parkinson Disease
Slide Presentation Diagnosis and Prognosis of New Onset Parkinson Disease
Patient Summary Diagnosis, Prognosis, and Treatments for Newly Diagnosed Parkinson Disease
Slide Presentation Neuroprotective Strategies and Alternative Therapies for Parkinson Disease
Clinician Summary Evaluation and Treatment of Depression, Psychosis, and Dementia in Parkinson Disease
Patient Summary Medical and Surgical Treatment for Motor Fluctuations and Dyskinesia in Parkinson Disease
Clinician Summary Medical and Surgical Treatment of Parkinson Disease with Motor Fluctuations and Dyskinesia
Patient Summary Screening and Treatment for Depression, Dementia, and Psychosis in Parkinson Disease
Slide Presentation Evaluation and Treatment of Depression, Psychosis, and Dementia in Parkinson Disease
PDA Version Treatment of Parkinson Disease with Motor Fluctuations and Dyskinesia
PDA Version Diagnosis and Prognosis of New Onset Parkinson Disease
PDA Version Evaluation Treatment of Depression, Psychosis and Dementia in Parkinson Disease
PDA Version Neuroprotective Strategies and Alternative Therapies for Parkinson Disease
PDA Version Initiation of Treatment for Parkinson’s Disease
PDA Version Therapies for Essential Tremor
Patient Summary Therapies for Essential Tremor
Clinician Summary Therapies for Essential Tremor
Slide Presentation Therapies for Essential Tremor
back to top

Multiple Sclerosis
Guidelines
Mar 2007 Neutralizing antibodies to interferon-beta:assessment of their clinical and radiographic impact
Note:Current Guideline. Clinician summary, patient summary, and slide presentation available.
Nov 2003 The Use of Mitoxantrone (Novantrone) for the Treatment of Multiple Sclerosis
Note: Under revision 12/09/2006.
Sep 2003 Utility of MRI in Suspected MS
Note: Current guideline-reaffirmed 10/23/2005. Supplemental data, clinician summary, and patient and caregiver summary available.
Dec 2002 Immunization and Multiple Sclerosis: A Summary of Published Evidence and Recommendations
Note: Current guideline. Reaffirmed on 12/09/2006.
Feb 2002 Disease Modifying Therapies in Multiple Sclerosis
Note: Current guideline-reaffirmed 10/17/2003. Replaces Practice advisory on selection of patients with multiple sclerosis for treatment with Betaseron. Supplemental data available.
Jun 2000 The Role of Corticosteroids in the Management of Acute Monosymptomatic Optic Neuritis
Note: Under revision 10/15/2005. Reaffirmed 10/18/2003.
May 2000 The Usefulness of Evoked Potentials in Identifying Clinically Silent Lesions in Patients with Suspected Multiple Sclerosis
Note: Current guideline-reaffirmed on 01/13/2007 and 10/18/2003.
Jun 1999 The Relationship of MS to Physical Trauma and Psychological Stress
Note: Current guideline-reaffirmed 10/17/2003.
Tools
Clinician Summary Neutralizing Antibodies to Interferon-beta: Assessment of their Clinical and Radiographic Impact
Patient Summary Neutralizing Antibodies to Interferon-beta: Assessment of their Clinical and Radiographic Impact
Slide Presentation Neutralizing Antibodies to Interferon-beta: Assessment of their Clinical and Radiographic Impact: An Evidence Report
Background/Data Utility of MRI in Suspected MS
Note: Supplemental data.
Clinician Summary Utility of MRI in Suspected MS
Patient Summary Utility of MRI in Suspected MS
Background/Data Disease Modifying Therapies in Multiple Sclerosis
Note: Supplemental Data
back to top

Neuromuscular
Guidelines
Jun 2006 Practice Advisory: Utility of Surgical Decompression for Treatment of Diabetic Neuropathy
Note: Current guideline. Clinician summary and patient and caregiver summary available.
Jan 2005 Distal Symmetric Polyneuropathy: A Definition for Clinical Research
Note: Reaffirmed on 02/08/2008. Current case definition.
Sep 2003 Immunotherapy for Guillain-Barré Syndrome
Note: Current guideline-reaffirmed 10/15/2005. Supplemental data, slide presentation, clinician summary, and patient and caregiver summary available.
Mar 2003 Quantitative Sensory Testing
Note: Current guideline-reaffirmed 10/23/2005.
Sep 1999 Electrodiagnostic Studies in Ulnar Neuropathy at the Elbow
Note: Current guideline-reaffirmed 07/28/2006 and 10/18/2003.
Apr 1999 The Care of the Patient with Amyotrophic Lateral Sclerosis
Note: Under revision 10/15/2005. Reaffirmed 10/18/2003. Symptoms management remains the mainstay for treating ALS patients. Clinician summary available.
Sep 1997 Practice Advisory on the Treatment of Amyotrophic Lateral Sclerosis with Riluzole
Note: Current guideline-reaffirmed on 01/13/2007 and 10/18/2003.
Tools
Patient Summary Utility of Surgical Decompression for Treatment of Diabetic Neuropathy
Clinician Summary Utility of Surgical Decompression for Treatment of Diabetic Neuropathy
Slide Presentation Immunotherapy for Guillain-Barré Syndrome
Note: PowerPoint presentation based on the Immunotherapy for Guillain-Barré Syndrome guideline. Download slide presentation and use in grand rounds, lectures, or education settings.
Background/Data Immunotherapy for Guillain-Barré Syndrome
Note: Supplemental data.
Patient Summary Immunotherapy for Guillain-Barré Syndrome
Clinician Summary Immunotherapy for Guillain-Barré Syndrome
Clinician Summary Care of the Patient with Amyotrophic Lateral Sclerosis
back to top

Stroke and Vascular Neurology
Guidelines
Sep 2005 Carotid Endarterectomy
Note: Current guideline. Reaffirmed on 02/09/2008. Slide presentation, clinician summary, patient and caregiver summary and PDA version of guideline available.
Apr 2004 Recurrent Stroke in Patients with Patent Foramen Ovale and Atrial Septal Aneurysm
Note: Current guideline. Reaffirmed on 07/21/2007. Slide presentation, clinician summary and PDA version of guideline available.
Jul 2002 Anticoagulants and Antiplatelet Agents in Acute Ischemic Stroke
Note: Current guideline-reaffirmed 10/15/2005 and 10/17/2003. Supplemental data and PDA version of guideline available. Review this guideline and updates at http://www.americanheart.org/presenter.jhtml?identifier=3004586
Sep 1998 Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation
Note: Update in progress.
Sep 1996 Thrombolytic Therapy for Acute Ischemic Stroke Practice Advisory
Note: Current guideline-reaffirmed 2/18/2003.
Tools
PDA Version Anticoagulants and Antiplatelet Agents in Acute Ischemic Stroke
PDA Version Recurrent Stroke With Patent Foramen Ovale and Atrial Septal Aneurysm
PDA Version Carotid Endarterectomy
Patient Summary Carotid Endarterectomy
Slide Presentation Carotid Endarterectomy
Clinician Summary Carotid Endarterectomy
Clinician Summary Recurrent Stroke in Patients with Patent Foramen Ovale and Atrial Septal Aneurysm
Slide Presentation Recurrent Stroke in Patients with Patent Foramen Ovale and Atrial Septal Aneurysm
Note: PowerPoint presentation based on the risk of recurrent stroke and secondary stroke prevention in patients with interatrial septal abnormalities guideline. Download slide presentation and use in grand rounds, lectures, or education settings.
Background/Data Anticoagulants and Antiplatelet Agents in Acute Ischemic Stroke
Note: Supplemental data.
back to top

Technology Assessments
Guidelines
Sep 2005 Carotid Endarterectomy
Note: Current guideline. Reaffirmed on 02/09/2008. Slide presentation, clinician summary, patient and caregiver summary and PDA version of guideline available.
Sep 2005 Use of Serum Prolactin in Diagnosing Epileptic Seizures
Note: Current guideline. PowerPoint educational tool and PDA version available.
Aug 2005 Addendum to Assessment: Prevention of post-lumbar puncture headaches
Note: Current guideline. Reaffirmed on 02/09/2008. See Addendum to Prevention of Post-lumbar Puncture Headache (10/2000). PDA version available.
May 2004 Transcranial Doppler Ultrasonography UPDATED
Note: Current guideline-reaffirmed on 11/3/2007. Slide presentation, background data and clinician summary available.
Mar 2003 Quantitative Sensory Testing
Note: Current guideline-reaffirmed 10/23/2005.
Nov 2000 Vestibular Testing Techniques in Adults and Children
Note: Current guideline.
Oct 2000 Prevention of Post-Lumbar Puncture Headache
Note: See Addendum: Prevention of post-lumbar puncture headaches 08/2005.
Sep 1999 Reassessment: Vagus Nerve Stimulation for Epilepsy (UPDATED)
Note: Guideline under update. Guideline was reaffirmed on 10/17/2003. Supplement to Assessment of vagus nerve stimulation for epilepsy (07/1997).
Aug 1998 Review of the Literature on Spinal Ultrasound for the Evaluation of Back Pain and Radicular Disorders
Note:Current guideline-reaffirmed on 12/09/2006 and 10/17/2003.
Oct 1997 Dermatomal Somatosensory Evoked Potentials
Note: Retired on 07/20/2007. Reaffirmed 10/17/2003.
Jul 1997 Digital EEG, Quantitative EEG, and EEG Brain Mapping
Note: Current guideline-reaffirmed on 12/09/2006 and 10/17/2003. Replaces Assessment of digital EEG, quantitative EEG, and EEG brain mapping (08/1989).
Sep 1996 Plasmapheresis
Note: Update in progress.
Aug 1996 Neuropsychological Testing of Adults
Note: Retired 07/28/2006. Not available to download.
Mar 1996 Clinical Autonomic Testing
Note: Update in process as of 10/23/2005. Reaffirmed on 02/09/2008.
Mar 1994 Melodic Intonation Therapy
Note:Update in progress 12/09/2006. Current guideline-reaffirmed 10/17/2003.
Feb 1992 Techniques in the Diagnosis and Management of Sleep Disorders
Note: Update in progress.
Jan 1992 Magnetoencephalography (MEG)
Note: Update in progress and not available to download at this time.
Nov 1990 Intraoperative Neurophysiology
Note: Update in progress and not available to download at this time.
Tools
Clinician Summary Carotid Endarterectomy
Slide Presentation Carotid Endarterectomy
Slide Presentation Use of Serum Prolactin in Diagnosing Epileptic Seizures
Patient Summary Carotid Endarterectomy
Background/Data Transcranial Doppler Ultrasonography (UPDATED)
Note: Supplemental data.
Clinician Summary Transcranial Doppler Ultrasonography (UPDATED)
Slide Presentation Transcranial Doppler Ultrasonography (UPDATED)
Note: PowerPoint presentation based on the TCD guideline. Download slide presentation and use in grand rounds, lectures, or education settings.
back to top

Other
Guidelines
Feb 2008 Practice Parameter: Assessing patients in a neurology practice for risk of falls (an evidence-based review)
Note:Current guideline. Clinician summary , Patient and Caregiver summary, Case Study and Coding and Slide Presentation available.
May 2007 Treatment of Nervous System Lyme Disease
Note:Current guideline. Clinician summary, patient and caregiver summary, Case Study, and slide presentation are available.
Apr 2007 The medical treatment of ocular myasthenia (an evidence-based review)
Note: Current guideline. Background data available.
Mar 2007 Assessment: Use of epidural steroid injections to treat radicular lumbosacral pain
Note:Current Guideline. Clinician summary, patient summary, and slide presentation available.
Aug 2005 Addendum to Assessment: Prevention of post-lumbar puncture headaches
Note: Current guideline. Reaffirmed on 02/09/2008. See Addendum to Prevention of Post-lumbar Puncture Headache (10/2000). PDA version available.
Jan 2005 Distal Symmetric Polyneuropathy: A Definition for Clinical Research
Note: Reaffirmed on 02/08/2008. Current case definition.
Sep 2004 Treatment of Postherpetic Neuralgia
Note: Current guideline. Reaffirmed on 02/08/2008. Clinician summary, patient and caregiver summary of guideline, and slide presentation are available.
Apr 2001 Steroids, Acyclovir, and Surgery for Bell's Palsy
Note: Under update. This guideline was reaffirmed on 2/13/2004.
Oct 2000 Prevention of Post-Lumbar Puncture Headache
Note: See Addendum: Prevention of post-lumbar puncture headaches 08/2005.
Jul 2000 Thymectomy for Autoimmune Myasthenia Gravis
Note: Current guideline. Reaffirmed 10/28/2006 and 10/18/2003.
May 2000 Anticonvulsant Prophylaxis in Patients with Newly Diagnosed Brain Tumors
Note: Current guideline-reaffirmed 10/18/2003.
May 1999 Neurologic Risk of Immunization
Note: Update in progress. Replaces Assessment DTP vaccination (03/1992).
Jan 1998 Evaluation and Management of Intracranial Mass Lesions in AIDS
Note:Current guideline-reaffirmed on 01/13/2007 and 10/18/2003.
Jun 1997 Silicon Breast Implants and Neurologic Disorders
Note: Current guideline-reaffirmed on 03/31/2007 and 10/23/2005.
Nov 1996 Genetic Testing Alert
Note: Current guideline.
Mar 1996 Diagnosis of Patients with Nervous System Lyme Borreliosis (Lyme Disease)
Note: Current guideline. Reaffirmed 10/28/2006 and 10/18/2003.
Dec 1995 Neurological Evaluation of Male Sexual Dysfunction
Note: Update in progress.
Apr 1994 Magnetic Resonance Imaging in the Evaluation of Low-Back Syndrome
Note: Current guideline. Reaffirmed on 07/24/2004.
Mar 1994 Melodic Intonation Therapy
Note:Update in progress 12/09/2006. Current guideline-reaffirmed 10/17/2003.
Feb 1992 Techniques in the Diagnosis and Management of Sleep Disorders
Note: Update in progress.
Sep 1990 Botulinum Toxin-A in Treating Neurologic Disorders
Note: Update in progress and not available to download at this time.
Tools
Case Study Case Study: Risk of Falls,Coding and Patient Safety Tip
Clinician Summary Assessing Patients In A Neurology Practice For Risk Of Falls
Patient Summary Assessing Your Risk For Falls
Slide Presentation Assessing Patients In A Neurology Practice For Risk Of Falls
Clinician Summary Use of epidural steroid injections to treat radicular lumbosacral pain
Patient Summary Use of epidural steroid injections to treat radicular lumbosacral pain
Slide Presentation Treatment of Nervous System Lyme Disease
Case Study Lyme Disease Case Study: Treatment & Coding
Note:Case presentation on the Treatment and Coding of Nervous System Lyme Disease
Patient Summary Treatment of Nervous System Lyme Disease
Clinician Summary Treatment of Nervous System Lyme Disease
Background/Data The medical treatment of ocular myasthenia (an evidence-based review)
Slide Presentation Use of epidural steroid injections to treat radicular lumbosacral pain
Note:Current guideline. Clinician summary, patient summary, and slide presentation are available.
Clinician Summary Treatment of Postherpetic Neuralgia
Patient Summary Treatment of Postherpetic Neuralgia
Slide Presentation Treatment of Posthepetic Neuralgia
Note: PowerPoint presentation based on the treatment of postherptic neuralgia guideline. Download slide presentation and use in grand rounds, lectures, or education settings.
back to top

    

Guideline Tools

This CD-ROM contains a variety of guideline companion tools, including:

Patient/Caregiver Guideline Summaries

Use the patient/caregiver summaries to describe to your patients and their families how you will diagnose, evaluate, and treat their condition based on the evidence. Print and duplicate as needed to share with patients and place in your office or waiting room.

Clinician Guideline Summaries

Clinician summaries conveniently provide essential information from the guideline. Refer to the clinician summary when making diagnosis and treatment decisions. Print clinician summaries and keep them handy for quick and easy reference.

Presentation Tools

Share presentations based on practice guideline evidence with your colleagues, at state society meetings, in grand rounds, and with residents and medical students. Insert these slides in your presentations.

Case Studies

Vignettes bring the guidelines to life through tangible examples of clinical scenarios.  Included with the cases are coding, billing, and patient safety tips as applicable.

Guideline Purpose & Process

The AAN develops clinical practice guidelines to assist its members in clinical decision making—particularly in situations of controversy or variation in practice.

Most Common Uses for AAN Guidelines:

  • Improve health outcomes for patients
  • Stay abreast of the latest in clinical research
  • Appeal payment denials
  • Provide medico-legal protection
  • Advocate for fair reimbursement
  • Determine whether your practice follows current, best evidence
  • Affirm the role of neurologists in the diagnosis and treatment of neurological disorders
  • Influence public or hospital policy
  • Promote efficient use of resources
  • Identify research priorities based on gaps in current literature
  • Reduce inappropriate practice variation

Guideline Development Process

The Quality Standards Subcommittee (QSS) develops practice parameters and practice advisories. The Therapeutics and Technology Assessment Subcommittee (TTA) develops technology assessments. Both subcommittees form expert panels to critically assess all of the relevant literature on a given topic or technology. Evidence is rated based on quality of study design, and clinical practice recommendations are developed and stratified to reflect the quality and the content of the evidence.

Key Steps of the Process

  1. Select guideline topic
  2. Form panel of experts
  3. Develop clinical questions
  4. Comprehensive review of literature
  5. Summarize findings of evidence
  6. Make explicit, evidence-based practice recommendations
  7. Extensive peer review of guideline draft
  8. AAN approval of guideline

AAN Guidelines Are "Above the Fray"

The editorial below discusses the transparency and rigor of the American Academy of Neurology guideline development process.

Franklin, G.M.; Zahn, C.A. AAN clinical practice guidelines: above the fray. NEUROLOGY 2002; 59: 975-976.

A Neurologist's Guide to Guidelines

A Neurologist's Guide to Guidelines written by Janis Miyasaki, MD, FAAN and Esther Bui, BSc, MD.

Additional Guideline Resources

Full-text guidelines are also available on the web at www.aan.com or by contacting AAN Member Services at memberservices@aan.com or (800) 879-1960.

This resource includes guidelines published between January 1995 and February 2008. Please visit the AAN Website for information on guidelines published after February 2008.

The AAN Pocket Guidelines provide concise summaries of AAN guidelines in a pocket-sized book or on PDA. To obtain this invaluable reference please contact AAN Member Services at memberservices@aan.com or (800) 879-1960 or visit the AAN Website at www.aan.com.

Adobe Acrobat Reader

Adobe® Acrobat® Reader® is required to view the guidelines.  Please visit www.adobe.com to obtain a free version of the software.